Beyond the initial ten medications chosen for Medicare's inaugural price negotiations, these 30 drugs represent the highest Medicare Part D expenditure in 2021 and are thus potential contenders for future pricing discussions.
(Please use a modern browser to see the interactive version of this visualization)